Management of coccidioidomycosis first involves recognizing that a coccidioidal infection
exists, defining the extent of infection, and identifying host factors that predispose to disease …

Invasive fungal diseases (IFDs) have become major causes of morbidity and mortality
among highly immunocompromised patients. Authoritative consensus criteria to diagnose …

This report updates and combines earlier versions of guidelines for the prevention and
treatment of opportunistic infections (OIs) in HIV-infected adults (ie, persons aged> 18 years) …

With increasing numbers of immune-compromised patients with malignancy, hematologic
disease, and HIV, as well as those receiving immunosupressive drug regimens for the …

This report updates and combines into one document earlier versions of guidelines for
preventing and treating opportunistic infections (OIs) among HIV-exposed and HIV-infected …

This report presents the recommendations of the WHO Expert Committee responsible for
updating the WHO Model Lists of Essential Medicines.. The goal of the meeting was to …

The persistence of high morbidity and mortality from systemic fungal infections despite the
availability of novel antifungals points to the need for effective treatment strategies …

We performed a retrospective cohort study, using the 2002 Nationwide Inpatient Sample, a
national database of hospital inpatient stays, to describe the incidence and epidemiology of …

Coccidioidomycosis is a fungal disease with protean manifestations endemic to the Lower
Sonoran Life Zone, which includes the hot deserts of the southwestern United States and …

Summary The National Institutes of Health, the HIV Medicine Association of the Infectious
Diseases Society of America, and CDC have developed guidelines for treatment of …